Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetowhitening Time as a Novel Objective Tool for the Diagnosis of High Risk Neoplasia in Barrett's Oesophagus

NCT01618643 is registered in ClinicalTrials.gov with Portsmouth Hospitals NHS Trust as lead sponsor.

NCT NCT01618643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01618643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetowhitening Time as a Novel Objective Tool for the Diagnosis of High Risk Neoplasia in Barrett's Oesophagus
Lead sponsor
Portsmouth Hospitals NHS Trust
Phase
Observational
Overall status
Completed
Start date
November 23, 2010
Completion date
September 30, 2012
Enrollment
197 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett adenocarcinoma, barrett esophagus, barrett metaplasia, barrett oesophagitis with dysplasia